Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The factors responsible for fasting hyperglycemia were investigated in 77 normal weight non-insulin-dependent diabetic (NIDD) and 72 age-, sex-, and weight-matched control individuals. In diabetic subjects with mild fasting hyperglycemia (less than 140 mg/dL) hepatic glucose production (1.85 +/- 0.03 mg/kg.min) was similar to controls (1.84 +/- 0.02); the major factor responsible for the elevated basal glucose level in the diabetic group was a decreased efficiency in the tissue uptake of glucose, as reflected by a 30% decline in the rate of glucose clearance (1.56 +/- 0.03 v 2.00 +/- 0.03 mL/kg.min, P less than .001). In contrast, in diabetic subjects with fasting plasma glucose concentrations above 140 mg/dL, basal hepatic glucose production was significantly elevated (2.42 +/- 0.08 mg/kg.min, P less than .001) and correlated closely with the increase in fasting plasma glucose concentration (r = .796, P less than .001). The basal rate of whole body glucose clearance reached a plateau value at fasting glucose levels of 160 to 180 mg/dL and did not contribute to the further rise in fasting plasma glucose concentrations above 160 to 180 mg/dL. Decreased efficiency of tissue glucose uptake is responsible the development of fasting hyperglycemia in patients with mild NIDDM (fasting plasma glucose less than 140 mg/dL). As the diabetic state worsens, an increase in basal hepatic glucose production is the major factor responsible for the progressive rise in fasting glucose levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, hepatic glucose production is the main determinant of the fasting plasma glucose concentration and is regulated primarily by the plasma insulin and, to a lesser extent, glucagon concentrations ( 20 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [20]
In the citing paper
“IFG seems to be associated with ß-cell dysfunction (impaired insulin secretion) and an increase of the hepatic glucose output (DeFronzo 1989).”
From Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus (2017) · cites this paper as DeFronzo 1989
Citations
Cites
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Self-citationPlasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Rossetti, L., Smith, D., Shulman, G. I., Papachristou, D., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112981 · Cited by 809
Self-citationKolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
DeFronzo, R. A., Simonson, D., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 541
Self-citationRegulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man
DeFronzo, R. A., Ferrannini, E., Hendler, R., Felig, P., & Wahren, J. (1983) · Diabetes · doi:10.2337/diab.32.1.35 · Cited by 509
Self-citationThe Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488
Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
Bonner-Weir, S., Trent, D. F., & Weir, G. C. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110910 · Cited by 467
Research works printed but not linked: 4
- Groop, 1986, Suppression of FFA turnover and FFA oxidation by insulin is impaired in NIDDM, Diabetes, 35, 39A
- Sheehan, 1986, Effect of prolonged hyperinsulinemia on glucose metabolism, Diabetes, 35, 16A
- Bogardus, 1984, Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin dependent diabetic subjects, J Clin Invest, 74, 1238, 10.1172/JCI111533 · DOI · Paper page
- Kosaka, 1980, Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment, Diabetologia, 18, 23, 10.1007/BF01228297 · DOI · Paper page
Cited by
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
“The relationship between basal HGP and fasting plasma glucose (FPG) concentration is shown on the right (1,25).”
BackgroundSelf-citationNonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
“The HOMA measure, which considers only glucose and insulin concentrations under fasting, nondynamic conditions, is expected to give a picture of basal insulin effects, mainly on the liver, considering the importance of HGP on fasting hyperglycemia (35).”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Self-citationThe Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Self-citation
Metadata
- Authors
- DeFronzo, R. A., Ferrannini, E., & Simonson, D. C.
- Affiliations
- Yale University (US)
- Corresponding author
- DeFronzo, Ralph A.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 1989-04
- Volume
- 38
- Issue
- 4
- Pages
- 387-395
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W1969550954
- Cited by
- 515
- References
- 64
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 16 · 2018: 18 · 2017: 18 · 2016: 18 · 2015: 20 · 2014: 16 · 2013: 30 · 2012: 21
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- National Institute on Aging (AG00233)
- National Center for Research Resources (RR 125)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- fasting hyperglycemia, type 2 diabetes, hepatic glucose production, tissue glucose uptake, glucose clearance, fasting blood glucose, glucose homeostasis
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Female, Glucose, Humans, Hyperglycemia, Infusions, Intravenous, Insulin, Liver, Male, Metabolic Clearance Rate, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake. https://app.cochat.ai/papers/10.1016/0026-0495(89)90129-7
- The paper
- DeFronzo, R. A., Ferrannini, E., & Simonson, D. C. (1989). Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism. https://doi.org/10.1016/0026-0495(89)90129-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.